Supplementary Figure S1 from Hyper-Dependence on NHEJ Enables Synergy Between DNA-PK Inhibitors and Low-Dose Doxorubicin in Leiomyosarcoma

Supplementary Figure S1: A. Fraction of genome altered (FGA) in non-LMS cancers compared to LMS from GENIE v9.0 (37). B. FGA in LMS and in other tumor types in the GENIE dataset, including high grade sarcomas.